tiprankstipranks
Advertisement
Advertisement

SNDX Stock Latest News

Syndax price target raised to $46 from $45 at Stifel
The FlySyndax price target raised to $46 from $45 at Stifel
1d ago
SNDX
Syndax price target lowered to $37 from $40 at Jefferies
PremiumThe Fly
Syndax price target lowered to $37 from $40 at Jefferies
4d ago
SNDX
Analyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
PremiumRatings
Analyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
4d ago
SNDX
Syndax price target raised to $37 from $35 at Barclays
PremiumThe Fly
Syndax price target raised to $37 from $35 at Barclays
4d ago
SNDX
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Momentum, Longer Treatment Durations, and Emerging Niktimvo Upside
PremiumRatings
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Momentum, Longer Treatment Durations, and Emerging Niktimvo Upside
5d ago
SNDX
Syndax reports Q1 EPS (48c), consensus (59c)
PremiumThe FlySyndax reports Q1 EPS (48c), consensus (59c)
5d ago
SNDX
Syndax price target raised to $34 from $28 at Goldman Sachs
Premium
The Fly
Syndax price target raised to $34 from $28 at Goldman Sachs
1M ago
SNDX
Syndax price target lowered to $43 from $45 at Mizuho
Premium
The Fly
Syndax price target lowered to $43 from $45 at Mizuho
1M ago
SNDX
Syndax assumed with a Buy at Jefferies
PremiumThe Fly
Syndax assumed with a Buy at Jefferies
1M ago
KURA
SNDX
Syndax price target raised to $45 from $33 at JPMorgan
PremiumThe Fly
Syndax price target raised to $45 from $33 at JPMorgan
2M ago
SNDX
Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push
PremiumCompany Announcements
Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push
2M ago
SNDX
Syndax price target raised to $57 from $51 at Citi
PremiumThe Fly
Syndax price target raised to $57 from $51 at Citi
2M ago
SNDX
Syndax reports Q4 EPS (78c), consensus (58c)
PremiumThe FlySyndax reports Q4 EPS (78c), consensus (58c)
2M ago
SNDX
Syndax sees operating expense base remaining stable over next few years
Premium
The Fly
Syndax sees operating expense base remaining stable over next few years
2M ago
SNDX
SNDX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SNDX Upcoming Earnings Report: What to Expect?
2M ago
SNDX
Syndax price target raised to $28 from $27 at BofA
PremiumThe Fly
Syndax price target raised to $28 from $27 at BofA
3M ago
SNDX
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
PremiumCompany Announcements
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
3M ago
SNDX
Syndax Pharmaceuticals: Strong Revuforj Momentum, Underappreciated Pipeline Catalysts Support Attractive Risk/Reward and Buy Rating
PremiumRatings
Syndax Pharmaceuticals: Strong Revuforj Momentum, Underappreciated Pipeline Catalysts Support Attractive Risk/Reward and Buy Rating
4M ago
SNDX
Syndax: Strong Revuforj and Niktimvo Momentum Undervalues Commercial Trajectory and Pipeline Upside
PremiumRatings
Syndax: Strong Revuforj and Niktimvo Momentum Undervalues Commercial Trajectory and Pipeline Upside
4M ago
SNDX
Syndax Highlights Strong 2025 Results and Path to Profitability
PremiumCompany AnnouncementsSyndax Highlights Strong 2025 Results and Path to Profitability
4M ago
8K
SNDX
Syndax announces expected milestones for 2026
Premium
The Fly
Syndax announces expected milestones for 2026
4M ago
SNDX
Syndax reports preliminary Q4 Revuforj revenue $44M
Premium
The Fly
Syndax reports preliminary Q4 Revuforj revenue $44M
4M ago
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >